Drug Precursors

US DEA Finalises List I Designation of P2P Methyl Glycidic Acid and Its Esters

The US DEA has designated P2P methyl glycidic acid and its esters as List I chemicals under the Controlled Substances Act, effective May 4, 2026. Impacted operators must secure DEA registrations and implement rigorous compliance controls, as the lack of a concentration threshold brings all mixtures containing these substances into scope.

6 Apr 2026, 16:07federalregister.govUnited States

EU Council Working Party on Customs Union To Examine Drug Precursors Monitoring And Control Regulation Proposal

EU Council negotiations on the recast Drug Precursors Monitoring and Control Regulation are advancing with a detailed article-by-article review scheduled for April 2026. This signals a move toward a unified and potentially more stringent oversight framework for the trade and monitoring of precursor chemicals across the EU.

2 Apr 2026, 09:23data.consilium.europa.euEuropean Union

Latvian Saeima Adopts Second Reading Of Pharmacy Law Amendments And Sets Third-Reading Deadline

Latvia has advanced amendments to its Pharmacy Law through the second reading, setting a deadline for final proposals in April 2026. Companies must prepare for potential shifts in pharmaceutical distribution and precursor controls as the legislation nears final adoption.

2 Apr 2026, 07:55titania.saeima.lvLatvia

US DEA Invites Comment on SpecGx LLC Bulk Manufacturer Registration for Schedule I and II Controlled Substances

The US DEA has announced an application by SpecGx LLC to register as a bulk manufacturer for a wide range of Schedule I and II controlled substances, including opioids, stimulants, and psychedelics. Existing manufacturers and applicants have until May 26, 2026, to submit comments or objections, a process that may influence future bulk supply dynamics and quota allocations for these highly regulated substances.

27 Mar 2026, 18:17govinfo.govUnited States

Honduras ARSA Updates Controlled Substances And Precursors List And Strengthens Control Regime

Honduras updated its controlled substances and precursors list on 24 February 2026, introducing immediate reporting obligations and new equipment import controls effective 10 April 2026. Companies must audit product compositions against new concentration thresholds and secure specialized equipment permits to ensure uninterrupted manufacturing and distribution operations.

27 Mar 2026, 17:14arsateca.arsa.hnHonduras

Argentina Adopts Decree 128/2026 Expanding Chemical Precursor Controls

Argentina has expanded its chemical precursor control regime by adding 56 substances to the National Register of Chemical Precursors, effective March 4, 2026. Impacted businesses must immediately verify registration and compliance for newly listed industrial solvents and reagents to avoid trade disruptions and legal penalties.

26 Mar 2026, 12:12boletinoficial.gob.arArgentina

US Congress Introduces H.R. 8005 To Amend Controlled Substances Act For Fentanyl And Counterfeit Substances

US House Bill H.R. 8005, introduced in March 2026, proposes amendments to the Controlled Substances Act to restrict fentanyl, its analogues, and counterfeit substances. The legislation signals intensified federal oversight and enforcement risks for supply chains, emphasizing the need for robust product integrity and compliance controls for high-risk substances.

24 Mar 2026, 13:23congress.govUnited States

US DEA Updates Exempt Chemical Preparations Under the Controlled Substances Act

The US DEA has updated the list of chemical preparations exempt from Controlled Substances Act (CSA) requirements, following a review of applications through late 2025. Companies must audit product portfolios against the new lists to confirm exemption status and ensure full compliance for non-exempt substances.

21 Mar 2026, 19:13govinfo.govUnited States

UN Commission on Narcotic Drugs Issues Draft Report Addendum on Synthetic Drugs and Access to Controlled Medicines (CND 69th Session)

The UN Commission on Narcotic Drugs (CND) has identified nitazenes, orphines, and designer precursors as priority targets for future international scheduling and control. Manufacturers should anticipate tighter global restrictions on these synthetic substance classes and increased monitoring of non-scheduled chemical precursors in supply chains.

14 Mar 2026, 15:21documents.un.orgGlobal

UN CND Circulates Revised Draft Resolution on Early Warning for New Synthetic Drugs and Precursors

The UN Commission on Narcotic Drugs is advancing a resolution to strengthen global early-warning systems for new synthetic drugs and chemical precursors. This signals an acceleration in international scheduling efforts, requiring businesses to monitor emerging precursor controls that could impact chemical supply chains.

14 Mar 2026, 08:23unodc.orgGlobal

US DEA Seeks Comment on Purisys, LLC Import Registration for Schedule I and II Controlled Substances

The US DEA has published a notice of application for Purisys, LLC to import various Schedule I and II controlled substances, with comments due by April 13, 2026. This move signals potential shifts in the domestic supply chain for pharmaceutical precursors and APIs, offering existing manufacturers a window to contest or support the expanded import capacity.

13 Mar 2026, 13:25federalregister.govUnited States

Canada Adopts Order Adding Five Fentanyl Precursors to Schedule VI of the Controlled Drugs and Substances Act (SOR/2026-38)

Canada is formalizing permanent controls for five fentanyl precursors under the Controlled Drugs and Substances Act, effective April 12, 2026. Impacted businesses must transition from temporary exemptions to full licensing and registration to ensure continued legal handling and supply chain compliance.

13 Mar 2026, 13:00gazette.gc.caCanada

Canada Amends Precursor Control Regulations To Add Four Fentanyl Precursors (SOR/2026-39)

Canada has added four fentanyl precursors to the Precursor Control Regulations, effective 12 April 2026. Companies handling these substances must now comply with strict licensing, permit, and record-keeping requirements to maintain legal market access and supply chain integrity.

13 Mar 2026, 10:52gazette.gc.caCanada

UN CND Circulates Revised Draft Resolution On Supply Chain Integrity For Narcotic Drugs And Psychotropic Substances

The UN Commission on Narcotic Drugs is progressing a resolution to tighten global supply chain integrity and shipping oversight for narcotic drugs and psychotropic substances. Companies handling controlled substances or precursors should prepare for enhanced traceability mandates and more rigorous scrutiny of international logistics and transport modalities.

12 Mar 2026, 11:59docs.un.orgGlobal

Slovakia – Ministry of Health Sets Out Permit and Reporting Requirements for Drug Precursors

Slovakia has transferred administrative oversight for drug precursor permits and reporting to the Ministry of Health, effective January 1, 2026. Affected businesses must transition to new submission portals and ensure alignment with the recurring February 15 annual reporting deadline to maintain market access.

12 Mar 2026, 11:30health.gov.skSlovakia

UN Commission on Narcotic Drugs: Peru Submits Countercyclical Strategy Against the Drug Trade

Peru has presented a "countercyclical" strategy to the UN Commission on Narcotic Drugs, shifting focus toward disrupting the economic value chains and chemical supply routes of illicit drug trafficking. This strategic shift signals a move toward more integrated, intelligence-led supply chain controls that may influence future international cooperation on drug precursor monitoring and enforcement.

12 Mar 2026, 07:19docs.un.orgPeruGlobal

US ONDCP Director Carter Highlights Fentanyl WMD Designation at UN Commission on Narcotic Drugs

The US has formally designated fentanyl and its precursors as Weapons of Mass Destruction, signaling a shift toward aggressive international enforcement and supply chain oversight. Businesses should anticipate heightened scrutiny of chemical precursor trade and more restrictive export controls as the US seeks global coordination on synthetic opioid precursors.

12 Mar 2026, 05:44whitehouse.govUnited States

EU Parliament Briefing Evaluates Impact Assessment for Drug Precursors Monitoring Proposal

The European Parliament has published its impact assessment briefing on the proposed recast of EU drug precursor regulations, signaling progress toward stricter controls on "designer precursors" and a unified digital reporting system. Businesses should prepare for enhanced "catch-all" enforcement and mandatory digital licensing, which aim to streamline compliance while closing loopholes for non-scheduled substances.

12 Mar 2026, 05:42europarl.europa.euEuropean Union

US DEA Finalises List I Chemical Designation For Propionyl Chloride Under CSA

The US DEA has designated propionyl chloride as a List I chemical under the Controlled Substances Act, effective 09 April 2026, with no concentration threshold for mixtures. Impacted businesses must secure DEA registrations, implement strict recordkeeping, and meet reporting requirements by the deadline to maintain legal market access for this fentanyl precursor.

11 Mar 2026, 17:34govinfo.govUnited States

EU Parliament INTA Allocates Drug Precursors Monitoring And Control Regulation Proposal To ECR Group

The EU Parliament’s INTA committee has formally initiated scrutiny of the proposed Drug Precursors Monitoring and Control Regulation by allocating the file to the ECR group. This marks the start of legislative negotiations to overhaul trade and monitoring rules, signaling future shifts in compliance obligations for chemical precursor trade.

11 Mar 2026, 13:05europarl.europa.euEuropean Union